These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 11547114)

  • 1. Cessation of prophylactic antibiotics for managing persistent vesicoureteral reflux.
    Thompson RH; Chen JJ; Pugach J; Naseer S; Steinhardt GF
    J Urol; 2001 Oct; 166(4):1465-9. PubMed ID: 11547114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux.
    Cooper CS; Chung BI; Kirsch AJ; Canning DA; Snyder HM
    J Urol; 2000 Jan; 163(1):269-72; discussion 272-3. PubMed ID: 10604374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome after discontinuing prophylactic antibiotics in children with persistent vesicoureteral reflux.
    Kitchens DM; Herndon A; Joseph DB
    J Urol; 2010 Oct; 184(4 Suppl):1594-7. PubMed ID: 20728116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of antibiotic prophylaxis discontinuation in patients with persistent vesicoureteral reflux initially presenting with febrile urinary tract infection: time to event analysis.
    Leslie B; Moore K; Salle JL; Khoury AE; Cook A; Braga LH; Bägli DJ; Lorenzo AJ
    J Urol; 2010 Sep; 184(3):1093-8. PubMed ID: 20650501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
    Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
    Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children.
    Swerkersson S; Jodal U; Sixt R; Stokland E; Hansson S
    J Urol; 2007 Aug; 178(2):647-51; discussion 650-1. PubMed ID: 17574623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High grade primary vesicoureteral reflux in boys: long-term results of a prospective cohort study.
    Alsaywid BS; Saleh H; Deshpande A; Howman-Giles R; Smith GH
    J Urol; 2010 Oct; 184(4 Suppl):1598-603. PubMed ID: 20728178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting early recurrent urinary tract infection in pretoilet trained children with vesicoureteral reflux.
    Yamazaki Y; Shiroyanagi Y; Matsuno D; Nishi M
    J Urol; 2009 Oct; 182(4 Suppl):1699-702. PubMed ID: 19692080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of grades III and IV primary vesicoureteral reflux in children with and without acute pyelonephritis as breakthrough infections: a comparative analysis.
    Yu TJ; Chen WF
    J Urol; 1997 Apr; 157(4):1404-6. PubMed ID: 9120964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal parenchymal damage in intermediate and high grade infantile vesicoureteral reflux.
    Mohanan N; Colhoun E; Puri P
    J Urol; 2008 Oct; 180(4 Suppl):1635-8; discussion 1638. PubMed ID: 18708232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with vesicoureteral reflux in children: clinical characteristics.
    Greenfield SP; Ng M; Wan J
    J Urol; 1997 Aug; 158(2):574-7. PubMed ID: 9224365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for breakthrough infection in children with primary vesicoureteral reflux.
    Shiraishi K; Yoshino K; Watanabe M; Matsuyama H; Tanikaze S
    J Urol; 2010 Apr; 183(4):1527-31. PubMed ID: 20172558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal dimercapto-succinic acid scan is a predictive factor of breakthrough urinary tract infection in children with primary vesicoureteral reflux.
    Nakamura M; Moriya K; Mitsui T; Tanaka H; Nonomura K
    J Urol; 2009 Oct; 182(4 Suppl):1694-7. PubMed ID: 19692059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal scarring and urinary tract infection after successful endoscopic correction of vesicoureteral reflux.
    Chertin B; Natsheh A; Fridmans A; Shenfeld OZ; Farkas A
    J Urol; 2009 Oct; 182(4 Suppl):1703-6. PubMed ID: 19692032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of children with vesicoureteral reflux with and without antibiotic prophylaxis.
    Georgaki-Angelaki H; Kostaridou S; Daikos GL; Kapoyiannis A; Veletzas Z; Michos AG; Syriopoulou VP
    Scand J Infect Dis; 2005; 37(11-12):842-5. PubMed ID: 16308218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can prophylactic antibiotics safely be discontinued in children with vesicoureteral reflux?
    Al-Sayyad AJ; Pike JG; Leonard MP
    J Urol; 2005 Oct; 174(4 Pt 2):1587-9; discussion 1589. PubMed ID: 16148658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing concepts concerning the management of vesicoureteral reflux.
    Herndon CD; DeCambre M; McKenna PH
    J Urol; 2001 Oct; 166(4):1439-43. PubMed ID: 11547107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early discontinuation of antibiotic prophylaxis in patients with persistent primary vesicoureteral reflux initially detected during infancy: outcome analysis and risk factors for febrile urinary tract infection.
    Moriya K; Mitsui T; Kitta T; Nakamura M; Kanno Y; Kon M; Nishimura Y; Shinohara N; Nonomura K
    J Urol; 2015 Feb; 193(2):637-42. PubMed ID: 25111912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of treated dysfunctional voiding on the nonsurgical management of vesicoureteral reflux.
    Snodgrass W
    J Urol; 1998 Nov; 160(5):1823-5. PubMed ID: 9783967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bladder malfunction, urinary tract infection and vesicoureteral reflux in children].
    Castro I; Soares E; Casimiro A; Nogueira G
    Acta Med Port; 1998 Jul; 11(7):635-42. PubMed ID: 9859510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.